Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.

NCT05216588 · clinicaltrials.gov ↗

COMPLETED

Status

149

Enrollment

OTHER_GOV

Sponsor class

Conditions

COVID-19
Immunocompromised Host

Sponsor

ANRS, Emerging Infectious Diseases